Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(7%)
Results Posted
38%(3 trials)

Phase Distribution

Ph not_applicable
3
21%
Ph phase_4
5
36%
Ph phase_2
2
14%
Ph phase_3
3
21%

Phase Distribution

0

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
3(23.1%)
Phase 4Post-market surveillance
5(38.5%)
N/ANon-phased studies
3(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(8)
Other(4)

Detailed Status

Completed8
unknown4
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (15.4%)
Phase 33 (23.1%)
Phase 45 (38.5%)
N/A3 (23.1%)

Trials by Status

recruiting17%
completed857%
unknown429%
not_yet_recruiting17%

Recent Activity

1 active trials
Showing 5 of 14
not_yet_recruiting

Amisulpride for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery

NCT07554040
recruitingphase_3

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

NCT07413809
completedphase_4

Efficacy of Three Antiemetics in Preventing Nausea and Vomiting

NCT05533281
completedphase_3

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

NCT05564286
unknownphase_4

A Pilot Trial Evaluating the Effect of Tropisetron on Postoperative Cognitive Dysfunction After Cardiac Surgery

NCT04195204
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07554040

Amisulpride for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery

Not Yet Recruiting
NCT07413809Phase 3

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Recruiting
NCT05533281Phase 4

Efficacy of Three Antiemetics in Preventing Nausea and Vomiting

Completed
NCT05564286Phase 3

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Completed
NCT04195204Phase 4

A Pilot Trial Evaluating the Effect of Tropisetron on Postoperative Cognitive Dysfunction After Cardiac Surgery

Unknown
NCT04027751Phase 4

The Efficacy and Safety of Tropisetron in Preventing Emergence Delirium

Unknown
NCT02625181Not Applicable

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Completed
NCT00435370Phase 3

Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia

Completed
NCT02576327Phase 4

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Unknown
NCT00003817Phase 2

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

Completed
NCT02096835Not Applicable

Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting

Completed
NCT01895010Phase 2

Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE

Unknown
NCT00970450Not Applicable

The Central Analgesic Effects of Paracetamol on Serotonergic Pathways

Completed
NCT00487110Phase 4

Clinical Confirmation of a Pharmacodynamic Interaction Between Tropisetron and Paracetamol

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14